Metraipolis › archive › dc_cceb785e4ae2

PRMT3 in cancer: arginine methylation as a driver of tumor metabolism, immune evasion, and therapeutic resistance — Europe PMC PMID:42148077

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42148077
DOI
10.3389/fimmu.2026.1828765
License (as archived)
solo-consultazione
Archived
2026-11-02T22:08:03.984Z
SHA-256 of the archived text
c58088e3f1c21aaf7c1288a1c55d9670c7c9a55aee48e1585f2b31d313962bf1
Stable URL of this page
https://metraipolis.com/documento/dc_cceb785e4ae2

How to cite

PRMT3 in cancer: arginine methylation as a driver of tumor metabolism, immune evasion, and therapeutic resistance — Europe PMC PMID:42148077 — Europe PMC (en), https://europepmc.org/article/MED/42148077 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cceb785e4ae2 (Metraipolis archive dc_cceb785e4ae2, sha256 c58088e3f1c21aaf7c1288a1c55d9670c7c9a55aee48e1585f2b31d313962bf1)
BibTeX
@misc{dccceb785e4ae2,
  title = {PRMT3 in cancer: arginine methylation as a driver of tumor metabolism, immune evasion, and therapeutic resistance — Europe PMC PMID:42148077},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42148077},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cceb785e4ae2; sha256 c58088e3f1c21aaf7c1288a1c55d9670c7c9a55aee48e1585f2b31d313962bf1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42148077. Agents can read the archived copy with the MCP tool read_document.